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Surgical conversion with graft salvage as a deﬁnitive
treatment for persistent type II endoleak causing
sac enlargement
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Vittorio Alberti, MD,a Stefano Fazzini, MD, PhD,a Felice Pecoraro, MD, PhD,c and Carlo Setacci, MD,b
Rome, Siena, and Palermo, Italy
Objective: The goal of this study was to present open surgical conversion with graft salvage or “semiconversion” as a
deﬁnitive and safe treatment for untreatable and persistent type II endoleaks causing sac enlargement after endovascular
aneurysm repair.
Methods: Between January 2001 and December 2014, 25 of 1623 endovascular aortic repair (EVAR) patients were
selected as candidates for open semiconversion. The indication was persistent type II endoleak in 13 patients (12 of whom
received previous attempts of embolization), type I and II endoleak in 2 patients, and sac growth without imaging
evidence of endoleak in the other 10. After the infrarenal aorta was prepared (via a retroperitoneal access, whenever
possible), the technique consisted of performing a banding of the neck with Teﬂon (DuPont, Wilmington, Del), a
sacotomy to remove the thrombus or the hygroma, or both, and then suturing all of the feeding vessels that were found.
Proximal and distal fenestrations were performed to avoid sac repressurization.
Results: The semiconversion was performed after a mean of 74 months after the initial EVAR. The mean aneurysm size at
the time of the EVAR was 6.0 cm (range, 5.0-9.5 cm), and the mean aneurysm size at the time of the semiconversion was
7.7 cm (range, 5.5-11.5 cm). The overall aneurysm size increase was 38%, and the average growth rate was 8.2% per year.
One patient had a stable aneurysm size but was treated because of an emergency condition. Technical success was 100%,
with resolution of the endoleak and no perioperative deaths. Four cardiac deaths were registered at 12, 26, 30, and
60 months (mean follow-up, 42 months; range, 1-80 months).
Conclusions: Graft salvage appears to be a valid option compared with open repair when considering treatment of
persistent type II endoleak. This case series shows that semiconversion is a safe and effective treatment for otherwise
untreatable type II endoleak. (J Vasc Surg 2015;62:1437-41.)
As endovascular aortic repair (EVAR) has been intro-
duced, a decreasing rate of total aneurysm-related deaths
has been reported, with EVAR becoming more and more
adopted in comparison to open repair.1,2 Some concerns
remain regarding the durability of the materials,3 because
the rate of reintervention reported in literature reaches
35%.4-6 Despite this, within 5 years, the percentage of pa-
tients with abdominal aortic aneurysm undergoing EVAR
in the United States increased from 39% to 72%, and the
number of patients undergoing open repair declined
dramatically.7,8 Any type of endoleak accounts for 83%
of the indications for reintervention. Furthermore, 65%
of reinterventions are caused by persistent type II endo-
leak,8 which is one of the most frequent complications
of EVAR, with an incidence of 10% to 30%.1-3
However, given the consistent percentage of stable or
regressive type II endoleak, the need for treatment remains
controversial.4,6,9 According to the European Collabora-
tors on Stent-Graft Techniques for Abdominal Aortic
Aneurysm Repair (EUROSTAR) database, most type II
endoleaks will thrombose spontaneously and have a benign
course.8 Treatment is considered only for large, high-ﬂow
endoleaks or in case of aneurysmal growth.7 The ﬁrst
step is usually embolization, which can be performed via
several access points and will cause the resolution of 80%
of the endoleaks. Laparoscopic ligation of the feeding ves-
sels has also been described.10,11 When the endoleak per-
sists and the sac enlarges, despite these procedures,
surgical conversion is advised.12 Nevertheless, complete
graft removal carries a high mortality risk.13 A less aggres-
sive option is surgical conversion with endograft salvage.
This technique was ﬁrst reported by Hinchliffe et al14 in
2002, and has since been sporadically reported in case re-
ports and small series.15,16
From the Vascular Surgery Department, San Filippo Neri Hospital, Romea;
the Vascular Surgery Department, Policlinico Santa Maria alle Scotte,
Sienab; and the Vascular Surgery Unit, AOUP “P. Giaccone,” University
of Palermo, Palermo.c
Author conﬂict of interest: none.
Presented at the International Fast Talk at the 2015 Vascular Annual
Meeting of the Society for Vascular Surgery, Chicago, Ill, June 17-
20, 2015.
Correspondence: Matteo Orrico, MD, Vascular Surgery Department, San
Filippo Neri Hospital, Via Martinotti 20, 00135 Rome, Italy (e-mail:
dr.orrico.matteo@gmail.com).
The editors and reviewers of this article have no relevant ﬁnancial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a conﬂict of interest.
0741-5214
Copyright  2015 by the Society for Vascular Surgery. Published by
Elsevier Inc.
http://dx.doi.org/10.1016/j.jvs.2015.07.075
1437
Author's personal copy
The aim of this study was to describe the open conver-
sion with graft salvage technique, or “semiconversion,”
and to present the mid- and long-term results of our 25
cases.
METHODS
This study conforms with the Declaration of Helsinki.
Informed consent was collected from every patient.
Patient selection. Between January 2001 and January
2015, 1623 EVAR procedures were performed at our insti-
tution. Data were prospectively collected in a database and
retrospectively reviewed. The follow-up method after
EVAR consisted of serial duplex ultrasound (DUS) imag-
ing, abdominal X-ray imaging, and routine physical exam-
inations at 1, 3, 6, and 12 months and yearly thereafter. A
contrast computed tomography (CT) scan was performed
whenever there was evidence of an endoleak or in case of
aneurysmal sac increase at the DUS examinations and
whenever a patient presented with symptoms that could
be related to the aneurysm. If sac growth was detected,
than the follow-up was intensiﬁed by performing a DUS
examination every 6 months, accompanied by contrast
CT scan examination at the ﬁrst 6-month control and
whenever evidence showed further increasing diameter.
The resolution of the type II endoleak was deﬁned by
its disappearance at the DUS or, in cases of prior sac in-
crease or treated patients, or both, at the CT scan control.
CT scans were retrospectively reviewed, and measurements
were done twice by the principal investigator and once by
another observer to ensure acceptable intraobserver and
interobserver variability.
The selection of the patients suitable for semiconversion
is summarized in Fig 1. We registered a 13% incidence of
persistent at type II endoleak at 1 year. Of those, 17% (2%
of the total) were accompanied by aneurysmal sac growth
with a maximum diameter >5 cm and were treated by our
group by embolizations through several access points: 35
transarterial, 12 translimb, and 7 transcaval. These were
assessed every 6 months thereafter with contrast CTs.
Two or more procedures were performed in 15 patients.
Of the persistent and growing type II endoleaks, 28 (78%)
were solved #1 year by endovascular means. However,
eight persisted >1 year after the diagnosis of type II endo-
leak, showing aortic growth, and underwent semiconver-
sion. Semiconversion was also performed in four patients
with type II endoleaks who had undergone endovascular
embolization attempts in other centers that had failed.
A patient with a stable type II endoleak was also treated
by semiconversion when he presented at our emergency
department, after 85 months of being lost at follow-up,
with abdominal pain and CT signs of an aortoenteric ﬁs-
tula. We treated this patient by semiconversion because
he was considered too fragile for a more aggressive removal
of the graft. He was 80 years old and with severe chronic
obstructive pulmonary disease and coronary artery disease.
A surgical repair of the ﬁstula (débridement and primary
closure) and semiconversion were concurrently performed
by multidisciplinary surgical team.
Two patients with associated type I and II endoleaks
were also treated by semiconversion. Other 10 patients un-
derwent semiconversion because of sac enlargement,
without any evidence of endoleak on the imaging. These
last 13 patients did not undergo any kind of endovascular
treatment.
Technique. At the beginning of our experience, we
performed the intervention with a median laparotomy,
but then, from December 2007, we preferred, when
feasible, a less aggressive standard retroperitoneal approach
through the 11th intercostal space, without rib resection or
reﬂection of the left kidney, so that 12 semiconversions
were performed via a standard retroperitoneal access.
Once the infrarenal aorta was prepared, we performed
preventive banding and reshaping of the neck with a Teﬂon
(DuPont, Wilmington, Del) band and consolidated the
graft to the aortic neck with four or ﬁve stitches binding
together the Teﬂon, the aortic wall, and the endograft.
The aim of banding and suturing was to prevent neck evo-
lution, graft migration, and loss of sealing that potentially
could come from traction applied during the intervention.
This step requires a minimal mobilization of the neck,
because we gain the posterior space by digitoclasy. The
Teﬂon banding of the neck is in our daily open repair prac-
tice. Despite the periaortic inﬂammation, this step was al-
ways relatively easy, probably because in our experience,
the neck was always not signiﬁcantly involved in the inﬂam-
mation process. After the proximal neck was secured, the
sac was opened longitudinally, and the thrombus or
hygromas, or both, was removed (Fig 2). We then sutured
all of the identiﬁed feeding vessels that were found and also
in instances of sac growth without imaging evidence of
type II endoleak. The sac was ﬁnally sutured leaving
some fenestrations to avoid repressurization with the
consequent risk of expansion and rupture. We always put
a drain in the sac and another in the retroperitoneal space
to drain the chyle coming from the inﬂamed periaortic tis-
sue and for early detection of a secondary hemorrhage. The
drains are kept in place from 1 to 3 days and until only
traces of chyle are present.
We monitored the resolution of the leak by the same
algorithm used to follow-up EVAR patients plus a contrast
CT scan control at 30 days after the semiconversion.
RESULTS
We treated 25 patients by partial conversion. The mean
age was 76.1 years. Associated comorbidities included
hypertension in 21 patients (84%), diabetes mellitus in 6
(24%), chronic obstructive pulmonary disease in 5 (20%),
coronary artery disease in 11 (44%), chronic renal failure
in 6 (24%), and dyslipidemia in 7 (28%). According to
the American Society of Anesthesiologists (ASA) Physical
Status Classiﬁcation, 17 patients were at ASA 3, 3 were
at ASA 2, and 5 were at ASA 4 The ASA classiﬁcation is
reported as stated at the time of the semiconversion.
The stent grafts originally implanted were Excluder
(W. L. Gore and Associates, Flagstaff Ariz) in 17 patients
(68%), Zenith (Cook Inc, Bloomington, Ind) in 3 (12%),
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Endurant (Medtronic, Sunnyvale, Calif.) in 1 (4%), Talent
(Medtronic) in 2 (8%) and Vanguard (Boston Scientiﬁc/
Scimed, Natick, Mass) in 2 (8%).
The procedure was done at an average of 73.52 months
(range 13-120 months) after the initial EVAR. The mean
aneurysm size at the time of EVAR was 5.8 cm (range,
5.0-9.5 cm), and the mean aneurysm size at the time of
semiconversion was 7.7 cm (range, 5.5-11.5 cm).
Only the patient with the aortoenteric ﬁstula had stable
aneurysm size (80 mm) after 85 months of follow-up. He
did not receive the preventive banding of the infrarenal
neck because of the high risk of infection of the Teﬂon felt.
The overall medium aneurysm size increase was of 38%,
and 39% if not excluding the patient with stable aneurysm
size. The mean rate of increase was 8.2% per year, but this
was not constant. A comparison of the 10 patients with sac
growth, without imaging evidence of type II endoleak,
showed a trend of more growth, faster, and over a similar
time period than the 13 type II endoleaks we observed.
Of the 13 evident type II endoleaks, only the patient
with the aortoenteric ﬁstula did not undergo an endovascu-
lar attempt due to his clinical condition. The 10 patients
with sac growth without imaging evidence of type II endo-
leak and the two patients with associated type I and II
Fig 1. Flow chart shows the selection of the population eligible for semiconversion. EL, Endoleak; EVAR, endo-
vascular aortic repair.
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endoleaks did not undergo any other treatment but the
semiconversion. We were able to preserve the graft in all
cases.
Twelve semiconversions were performed via a retroper-
itoneal access starting by 2007; from then, this approach
was preferred whenever possible. The mean operation
length was 3.9 hours, and the mean blood loss was
356 mL.
Blood transfusion was necessary only in the patient
with the aortoenteric ﬁstula. He received 2 units of blood
before and 1 unit during the intervention.
The mean hospital stay was 9.8 days. In-hospital
morbidity was 4% due to one pulmonary infection, which
was resolved #30 days. The mean follow-up after partial
conversion was 35.3 months (range, 1-70 months).
We recorded no procedure-related deaths. Four cardiac
deaths occurred at 12, 26, 30, and 60 months (mean follow-
up, 42 months; range, 1-80 months). All patients showed
complete resolution of the leak at the DUS examination
and at the 30-day contrast CT scan control. No patients
showed recurrence of sac growth during the follow-up.
DISCUSSION
Type II endoleak management is one of the most
controversial aspects of short-term and long-term follow-
up after EVAR.9,17,18 Even when feeding patent vessels
are not clearly present, but when there is evidence of sac
enlargement, authors have shown concern about the risk
of rupture and the evolution of sac dimensions.
Many techniques have been proposed to solve an evol-
utive endoleak, including endovascular techniques (embo-
lizations for instance), open repair, and laparoscopic
strategies.10,18,19
For only 78% of the 36 patients who underwent
endovascular treatment for type II endoleak of our original
population, the treatment was eventually effective. These
data are congruent with data from the literature.12,18
It is evident that the surgical strategy is considered as
the last resource because these patients, already borderline
for open surgery at the time of EVAR, usually become
more fragile during the time between the prior EVAR
and the semiconversion. In our experience, this time was
>6 years. The danger is even higher when complete graft
removal is proposed. This has been shown by some studies
that have compared small subgroups of open conversion
with and without graft salvage.20
Several authors16 have shown that graft salvage seems
to be a valid option compared with graft removal, because
in some comparative series, the mortality ranges from 1% to
4% when removing the graft and is 0 % when performing
sacotomy with graft salvage.20 This is, as far as we know,
the largest case series of semiconversions in the literature.
This technique, which was described ﬁrst by Hinchliffe
et al14 in 2002, permits resolution of the endoleak in
most cases by suturing the feeding vessel, and clamping
of the aorta is not necessary. Several small case series
were presented after the ﬁrst publication describing some
technical variations.12
Some authors12,21,22 underlined the concept of being
as least invasive as possible by performing a short incision
on the sac and not manipulating the landing zone. We
do not completely agree on this subject; we believe it is
worth performing a good sacotomy for the purpose of
searching for as many patent vessels with back bleeding
as possible. Furthermore, the preventive banding and su-
turing of the infrarenal neck, which obviously implies a
certain manipulation of the landing zone, if performed
effectively, is the fundamental maneuver to assure the sta-
bility of the graft and permanently avoid its migration after
a long time.
The laparoscopic approach has also been described as
useful in these instances, but we believe that a surgical
approach such as the one we described is more applicable
because it is in the toolbox of all vascular surgeons, and if
performed as we have described, should be considered
not strictly an invasive approach. In all cases, we found a
clear source of the sac enlargement, and we ﬁxed it using
our technique.
We believe that the main indication to semiconversion
should be any kind of sac growth post-EVAR, only after a
minimum of one failed endovascular embolization proce-
dure (where failed means continued sac enlargement dur-
ing the follow-up) and when any other embolization
attempts are feasible. We think that is inconvenient, for a
treatment of a growing sac, to realize more than three
failed embolization procedures.
We included in this series also a semiconversion per-
formed as an emergency concurrently with the repair of
an aortoenteric ﬁstula. We decided to treat this patient
by semiconversion because he was judged as being too
fragile for a more aggressive approach. After the surgical
repair of the ﬁstula, a semiconversion was performed to
treat the leak. The patient was then prescribed lifelong
antibiotic therapy. He is still alive and in good condition
after 12 months of follow-up. During our follow-up, we
never observed the persistence of type II endoleak and
sac growth.
Fig 2. Proximal banding of the neck and sacotomy.
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The long follow-up that we have for some of these pa-
tients (>6 years), together with the absence of adverse out-
comes, shows that this is a safe and effective “last-resource”
technique to treat sac enlargement after EVAR for persis-
tent type II endoleaks causing sac enlargement, even for
those patients who have been considered unﬁt for open
surgery.
CONCLUSIONS
Graft salvage appears to be a valid option compared
with open repair when considering treatment of persistent
type II endoleak. The results of this case series show that
this is a safe and effective treatment for endotherapy-
resistant type II endoleak causing sac enlargement.
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